Close

Wedbush Doubles Price Target on Anacor Pharmaceuticals (ANAC) to $20

March 22, 2013 8:50 AM EDT Send to a Friend
Wedbush doubled its price target on Outperform-rated Anacor Pharmaceuticals (NASDAQ: ANAC) from $10 to $20 following the announcement of positive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login